Back
Royal Gold Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
61
RGLD
Royal Gold
Last Price:
141.76
Seasonality Move:
-2.17%
Sell
14
ITCI
Intra-Cellular Therapies
Last Price:
73.33
Seasonality Move:
39.33%
Buy
61
Royal Gold (RGLD)
is a Buy
Is Royal Gold a Buy, Sell or Hold?
- The current Royal Gold [RGLD] share price is $145.57. The Score for RGLD is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RGLD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
14
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $73.21. The Score for ITCI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
RGLD Stock Price Chart
What is Royal Gold's stock price today?
-
The Royal Gold share price today is $145.57
The current trend is moderately bullish and RGLD is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $73.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
RGLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.36 | Buy |
| Relative Strength Index (14 RSI): | 63.07 | Buy |
| Chaikin Money Flow: | -325186 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (136.85 - 143.69) | Buy |
| Bollinger Bands (100): | (126.26 - 139.44) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 42.52 | Sell |
| Chaikin Money Flow: | -234523 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.04 - 75.68) | Sell |
| Bollinger Bands (100): | (68.39 - 76.99) | Buy |
RGLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 143.19 | Buy |
| 20-day SMA: | 140.15 | Buy |
| 50-day SMA: | 137.6 | Buy |
| 200-day SMA: | 124.6 | Buy |
| 8-day EMA: | 143.8 | Buy |
| 20-day EMA: | 141.21 | Buy |
| 50-day EMA: | 137.65 | Buy |
| 200-day EMA: | 127.56 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.4 | Sell |
| 20-day SMA: | 74.45 | Sell |
| 50-day SMA: | 75.51 | Sell |
| 200-day SMA: | 70.84 | Buy |
| 8-day EMA: | 74.91 | Sell |
| 20-day EMA: | 74.89 | Sell |
| 50-day EMA: | 74.57 | Sell |
| 200-day EMA: | 70.13 | Buy |
Royal Gold Earnings Growth & RGLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.28 per share, an increase this year of $1.37 per share, and an increase next year of $1.43 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Royal Gold Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||